What's Hot in Clinical Infectious Diseases? 2019 IDWeek Summary.
Publication/Presentation Date
4-1-2020
Abstract
The year 2019 brought about a multitude of innovations in clinical infectious diseases. With the continued rise of antimicrobial resistance (AMR), advances in diagnostics and newly available antibiotics offer additional strategies for combating this threat, but the broken antibiotic market serves as an impediment to further developments. The IDSA and other stakeholders are working to create novel pull incentives to stabilize the pipeline. Ongoing needs include developing optimal stewardship practices, including by using narrow-spectrum antibiotics and shorter durations of therapy. In the area of solid organ transplantation, early data from transplanting Hepatitis C virus (HCV)-infected organs are encouraging and the American Society of Transplantation (AST) released new guidelines addressing several key issues. Lastly, 2019 saw a resurgence in Measles emphasizing the importance of vaccination.
Volume
7
Issue
4
First Page
104
Last Page
104
ISSN
2328-8957
Published In/Presented At
Moss, S., & Boucher, H. W. (2020). What's Hot in Clinical Infectious Diseases? 2019 IDWeek Summary. Open forum infectious diseases, 7(4), ofaa104. https://doi.org/10.1093/ofid/ofaa104
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
32352020
Department(s)
Administration and Leadership
Document Type
Article